Analyst Reco. Globus Medical, Inc.

Equities

GMED

US3795772082

Market Closed - Nyse Other stock markets 04:00:02 2024-05-10 pm EDT			5-day change	1st Jan Change
64.72 ^USD	+0.56%		+24.58%	+21.45%

May. 10	Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing	MT
May. 09	Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Globus Medical Insider Sold Shares Worth $1,300,000, According to a Recent SEC Filing	May. 10	MT
Barclays Adjusts Price Target on Globus Medical to $85 From $83, Maintains Overweight Rating	May. 09	MT
Globus Medical Shares Rise After Stifel, Truist Adjust Price Targets Upwards	May. 08	MT
Stifel Adjusts Price Target on Globus Medical to $70 From $64, Maintains Buy Rating	May. 08	MT
Truist Securities Raises Price Target on Globus Medical to $63 From 60, Maintains Hold Rating	May. 08	MT
BTIG Upgrades Globus Medical to Buy From Neutral, Price Target is $60	Mar. 18	MT
Truist Securities Adjusts Price Target on Globus Medical to $60 From $58, Keeps Hold Rating	Feb. 21	MT
Stifel Adjusts Globus Medical's Price Target to $64 From $61, Keeps Buy Rating	Feb. 21	MT
Investors keep their cool despite inflation data	Jan. 11
Truist Adjusts Price Target on Globus Medical to $58 From $53, Maintains Hold Rating	Dec. 22	MT
Canaccord Genuity Adjusts Globus Medical's Price Target to $71 From $67, Keeps Buy Rating	Dec. 20	MT
RBC Cuts Price Target on Globus Medical to $70 From $77, Keeps Outperform Rating	Nov. 24	MT
Morgan Stanley Cuts Price Target on Globus Medical to $53 From $60, Maintains Equalweight Rating	Nov. 14	MT
Truist Securities Adjusts Price Target on Globus Medical to $53 From $58, Maintains Hold Rating	Nov. 08	MT
Roth MKM Starts Globus Medical With Buy Rating, Price Target is $75	23-10-20	MT
Stifel Upgrades Globus Medical to Buy From Hold, Cuts Price Target to $61 From $65	23-09-19	MT
Wells Fargo Lowers Price Target on Globus Medical to $58 From $63, Maintains Equal-Weight Rating	23-09-15	MT
Truist Securities Adjusts Price Target on Globus Medical to $65 From $68, Keeps Hold Rating	23-08-07	MT
Barclays Raises Price Target on Globus Medical to $77 From $75, Maintains Overweight Rating	23-08-07	MT
Truist Securities Adjusts Price Target on Globus Medical to $68 From $64, Maintains Hold Rating	23-07-19	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Globus Medical, Inc.

Equities

GMED

US3795772082

Analyst Reco.

Filters